| 1 |
Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking |
|
| | Guangping Liang,Tseyu Chung,Jinhua Guo,Rongrong Zhang,Wei Xü,Jason T. C. Tzen,Renwang Jiang | | | Chemical Research in Chinese Universities. 2017; 33(3): 378 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Document Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides |
|
| | Ho, H.-T., Liu, B., Snyder, J.S.,Hund, T.J., Györke, S. | | | Cardiovascular Research. 2014; 101(1): 165-174 | | | [Pubmed] [Google Scholar] | | | 3 |
Novel drug targets in clinical development for heart failure |
|
| | Melvin George,Muthukumar Rajaram,Elangovan Shanmugam,Thangavel Mahalingam VijayaKumar | | | European Journal of Clinical Pharmacology. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides |
|
| | Hsiang-Ting Ho,Bin Liu,Jedidiah S. Snyder,Qing Lou,Elizabeth A. Brundage,Florencia Velez-Cortes,Honglan Wang,Mark T. Ziolo,Mark E. Anderson,Chandan K. Sen,Xander H.T. Wehrens,Vadim V. Fedorov,Brandon J. Biesiadecki,Thomas J. Hund,Sándor Györke | | | Cardiovascular Research. 2014; 101(1): 165 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Neue medikamentöse therapieansätze bei akuter herzinsuffizienz | [Novel drug approaches in acute heart failure] |
|
| | Dietz, S., Werdan, K. | | | Arzneimitteltherapie. 2013; 31(9): 220-232 | | | [Pubmed] [Google Scholar] | |
|
